These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 30086875)

  • 1. Genetic causes and treatment of neonatal diabetes and early childhood diabetes.
    Barbetti F; D'Annunzio G
    Best Pract Res Clin Endocrinol Metab; 2018 Aug; 32(4):575-591. PubMed ID: 30086875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monogenic Forms of Diabetes Mellitus.
    Gaál Z; Balogh I
    Exp Suppl; 2019; 111():385-416. PubMed ID: 31588541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monogenic Diabetes Accounts for 6.3% of Cases Referred to 15 Italian Pediatric Diabetes Centers During 2007 to 2012.
    Delvecchio M; Mozzillo E; Salzano G; Iafusco D; Frontino G; Patera PI; Rabbone I; Cherubini V; Grasso V; Tinto N; Giglio S; Contreas G; Di Paola R; Salina A; Cauvin V; Tumini S; d'Annunzio G; Iughetti L; Mantovani V; Maltoni G; Toni S; Marigliano M; Barbetti F;
    J Clin Endocrinol Metab; 2017 Jun; 102(6):1826-1834. PubMed ID: 28323911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABCC8-related maturity-onset diabetes of the young: switching from insulin to sulphonylurea therapy: how long do we need for a good metabolic control?
    Evin F; Işık E; Onay H; Özen S; Darcan Ş; Gökşen D
    J Pediatr Endocrinol Metab; 2023 Jun; 36(6):592-597. PubMed ID: 37071846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maturity onset diabetes of the young: identification and diagnosis.
    McDonald TJ; Ellard S
    Ann Clin Biochem; 2013 Sep; 50(Pt 5):403-15. PubMed ID: 23878349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young.
    Ellard S; Colclough K
    Hum Mutat; 2006 Sep; 27(9):854-69. PubMed ID: 16917892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monogenic models: what have the single gene disorders taught us?
    Klupa T; Skupien J; Malecki MT
    Curr Diab Rep; 2012 Dec; 12(6):659-66. PubMed ID: 22996131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next generation sequencing targeted gene panel in Greek MODY patients increases diagnostic accuracy.
    Tatsi EB; Kanaka-Gantenbein C; Scorilas A; Chrousos GP; Sertedaki A
    Pediatr Diabetes; 2020 Feb; 21(1):28-39. PubMed ID: 31604004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical characteristics and genetic analysis of children and adolescents with monogenic diabetes].
    Fang J; Zhang P; Feng Y; Ding S; Yan L; Li H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2024 Jul; 41(7):783-789. PubMed ID: 38946358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Incidence of Heterozygous ABCC8 and HNF1A Mutations in Czech Patients With Congenital Hyperinsulinism.
    Rozenkova K; Malikova J; Nessa A; Dusatkova L; Bjørkhaug L; Obermannova B; Dusatkova P; Kytnarova J; Aukrust I; Najmi LA; Rypackova B; Sumnik Z; Lebl J; Njølstad PR; Hussain K; Pruhova S
    J Clin Endocrinol Metab; 2015 Dec; 100(12):E1540-9. PubMed ID: 26431509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and Clinical Characterization of Patients with Maturity-Onset of Diabetes of the Young (MODY): Identification of Novel Variations.
    Ateş EA; Üstay Ö; Polat H; Apaydın T; Elbasan O; Yıldırım Ö; Güney Aİ
    Balkan Med J; 2021 Sep; 38(5):272-277. PubMed ID: 34462253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfonylurea in the treatment of neonatal diabetes mellitus children with heterogeneous genetic backgrounds.
    Zhang M; Chen X; Shen S; Li T; Chen L; Hu M; Cao L; Cheng R; Zhao Z; Luo F
    J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):877-84. PubMed ID: 25781672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted next-generation sequencing reveals MODY in up to 6.5% of antibody-negative diabetes cases listed in the Norwegian Childhood Diabetes Registry.
    Johansson BB; Irgens HU; Molnes J; Sztromwasser P; Aukrust I; Juliusson PB; Søvik O; Levy S; Skrivarhaug T; Joner G; Molven A; Johansson S; Njølstad PR
    Diabetologia; 2017 Apr; 60(4):625-635. PubMed ID: 27913849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful maintenance on sulphonylurea therapy and low diabetes complication rates in a HNF1A-MODY cohort.
    Bacon S; Kyithar MP; Rizvi SR; Donnelly E; McCarthy A; Burke M; Colclough K; Ellard S; Byrne MM
    Diabet Med; 2016 Jul; 33(7):976-84. PubMed ID: 26479152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics and target identification in diabetes.
    Pearson ER
    Curr Opin Genet Dev; 2018 Jun; 50():68-73. PubMed ID: 29486427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of monogenic diabetes in the population-based Norwegian Childhood Diabetes Registry.
    Irgens HU; Molnes J; Johansson BB; Ringdal M; Skrivarhaug T; Undlien DE; Søvik O; Joner G; Molven A; Njølstad PR
    Diabetologia; 2013 Jul; 56(7):1512-9. PubMed ID: 23624530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of new mutation in maturity-onset diabetes of the young type 3 (MODY 3) responsive to a low dose of sulphonylurea.
    Jesić MD; Sajić S; Jesić MM; Maringa M; Micić D; Necić S
    Diabetes Res Clin Pract; 2008 Jul; 81(1):e1-3. PubMed ID: 18433912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics of type 2 diabetes mellitus and other specific types of diabetes; its role in treatment modalities.
    Kota SK; Meher LK; Jammula S; Kota SK; Modi KD
    Diabetes Metab Syndr; 2012; 6(1):54-8. PubMed ID: 23014256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical presentation and long-term outcome of patients with KCNJ11/ABCC8 variants: Neonatal diabetes or MODY in the DPV registry from Germany and Austria.
    Warncke K; Eckert A; Kapellen T; Kummer S; Raile K; Dunstheimer D; Grulich-Henn J; Woelfle J; Wenzel S; Hofer SE; Dost A; Holl RW
    Pediatr Diabetes; 2022 Nov; 23(7):999-1008. PubMed ID: 35822653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A successful transition to sulfonylurea treatment in male infant with neonatal diabetes caused by the novel abcc8 gene mutation and three years follow-up.
    Katanic D; Vorgučin I; Hattersley A; Ellard S; Houghton JAL; Obreht D; Knežević Pogančev M; Vlaški J; Pavkov D
    Diabetes Res Clin Pract; 2017 Jul; 129():59-61. PubMed ID: 28511139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.